Division of Allergy Pulmonary and Critical Care Medicine

Lorraine Ware, MD, center, poses with this year’s Medical Scholars Program students: from left, Justin Banerdt, Shilpa Mokshagundam, Nikhil Chavali, Jocelyn Gandelman, Jason Gandelman, Joshua Cockroft, Jennifer Marvin and Yemisi Dina.
February 7, 2019

Symposium shines light on research by medical students

The Vanderbilt University School of Medicine Medical Scholars Research Symposium was held Feb. 4 and highlighted the work of eight medical students who spent the 2017-2018 academic year immersed in research experiences under the guidance of faculty mentors.

By Kathy Whitney
October 22, 2018

Antipsychotics ineffective for treating ICU delirium: study

Critically ill patients are not benefiting from antipsychotic medications that have been used to treat delirium in intensive care units (ICUs) for more than four decades, according to a study released today in the New England Journal of Medicine.

By Craig Boerner
October 4, 2018

New center formed to treat, study ICU delirium, dementia

Millions of patients in intensive care units each year develop delirium during their hospitalization and often leave the hospital with cognitive deficits similar to those suffering from traumatic brain injury or mild Alzheimer’s disease.

By Nancy Humphrey
August 2, 2018

Connecting an asthma gene to leukemia

A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.

By Leigh MacMillan
July 12, 2018

Team explores diabetes drug’s ability to treat RSV infection

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.

By Leigh MacMillan
April 26, 2018

Ware elected VP of clinical investigation society

With last week’s election of Lorraine Ware, MD, as vice president of the American Society for Clinical Investigation (ASCI), two faculty members of the Vanderbilt University School of Medicine are among the current officers of the elite physician-scientist honor society.

By Bill Snyder
April 12, 2018

Alpha-gal found to be both a medication and red meat allergy

Alpha-gal allergy has commonly been referred to as “the red meat” allergy, but doctors at the Vanderbilt Asthma, Sinus and Allergy Program (ASAP) helped uncover that not only red meat, but some medications, can contain alpha-gal.
March 29, 2018

Sedative-associated delirium increases risk of dementia

A Vanderbilt study of more than 1,000 intensive care unit patients around the country, nearly three-fourths of whom experienced delirium, showed that many drugs given to sedate patients in the ICU are actually increasing their chances of — and duration of — delirium instead of helping them recover.
By Nancy Humphrey
March 27, 2018

Alzheimer’s proteins in ICU survivors

The cognitive impairment that affects patients who survive a stay in the ICU does not appear to have a similar mechanism to Alzheimer’s disease, Vanderbilt researchers have discovered.
By Meredith Jackson
February 27, 2018

Saline use on decline at Vanderbilt following landmark studies

Vanderbilt University Medical Center is encouraging its medical providers to stop using saline as intravenous fluid therapy for most patients, a change provoked by two companion landmark studies released Feb. 27 that are anticipated to improve survival and decrease kidney complications.
By Craig Boerner
February 15, 2018

Sepsis trial ranked No. 1 on critical care website

A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.
By Leigh MacMillan
February 12, 2018

Protecting transplanted lungs

Acetaminophen may offer a simple treatment to prevent tissue injury following lung transplant, Vanderbilt researchers have discovered.
By Leigh MacMillan
February 1, 2018

Study tracks therapy to slow idiopathic pulmonary fibrosis

Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to standard IPF treatments. The research team believes the drug may ultimately help slow progression of the chronic and progressive disease or reverse its course.
By Nancy Humphrey
1 … 7 8 9 10 11 … 13